Suppression of skin lesions by transdermal application of CpG-oligodeoxynucleotides in NC/Nga mice, a model of human atopic dermatitis

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 584-591

  Inoue, Joe ^a   Aramaki, Yukihiko ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; MESSENGER RNA;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INFLAMMATION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PRURITUS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 33845927900     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.584     Document Type: Article

References (39)

1. Nakamura, H., M. Aoki, K. Tamai, M. Oishi, T. Ogihara, Y. Kaneda, and R. Morishita. 2002. Prevention and regression of atopic dermatitis by ointment containing NF-κB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther. 9: 1221-1229.
2. Leung, D. Y., M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657.
3. Cooper, K. D. 1994. Atopic dermatitis: recent trends in pathogenesis and therapy. J. Invest. Dermatol. 102: 128-137.
4. Rudikoff, D., and M. Lebwohl. 1998. Atopic dermatitis. Lancet 351: 1715-1721.
5. Soter, N. A. 1989. Morphology of atopic eczema. Allergy 44(Suppl. 9): 16-19.
6. Uehara, M., R. Izukura, and T. Sawai. 1990. Blood eosinophilia in atopic dermatitis. Clin. Exp. Dematol. 15: 264-266.
7. Grewe, M., C. A. Bruijnzeel-Koomen, E. Schöpf, T. Thepen, A. G. Langeveld-Wildschut, T. Ruzicka, and J. Krutmann. 1998. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 19: 359-361.
8. H2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103: 1103-1111.
9. Vestergaard, C., H. Yoneyama, M. Murai, K. Nakamura, K. Tamaki, Y. Terashima, T. Imai, O. Yoshie, T. Irimura, H. Mizutani, and K. Matsushima. 1999. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104: 1097-1105.
10. van Bever, H. P. 1992. Recent advances in the pathogenesis of atopic dermatitis. Eur. J. Pediatr. 151: 870-873.
11. Nakayama, H. 1996. Atopic dermatitis. Dermatology 38: 484.
12. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor foxp3. Science 299: 1057-1061.
13. + T cells. Adv. Immunol. 81: 331-371.
14. + T regulatory cells on development, functional activation, and proliferation of Th2 cells. J. Immunol. 173: 267-274.
15. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20: 709-760.
16. Agrawal, S., and E. R. Kandimalla. 2003. Modulation of Toll-like receptor 9 responses through synthetic immunostimulatory motifs of DNA. Ann. NY Acad. Sci. 1002: 30-42.
17. Hemmi, H., T. Kaisho, K. Takeda, and S. Akira. 2003. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170: 3059-3064.
18. Klinman, D. M., D. Currie, I. Gursel, and D. Verthelyi. 2004. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol. Rev. 199: 201-216.
19. + regulatory T cells. J. Immunol. 173: 4433-4442.
20. Kondo, K., T. Nagami, and S. Todokoro. 1969. Differences in haematopoietic death among inbred strains of mice. In Comparative Cellular and Species Radiosensitivity. P. V. Bond, and T. Sugawara, eds. Igakusyoin, Tokyo, p. 20.
21. Vestergaard, C., H. Yoneyama, and K. Matsushima. 2000. The NC/Nga mouse: a model for atopic dermatitis. Mol. Med. Today 6: 209-210.
22. Matsuda, H., N. Watanabe, G. P. Geba, J. Sperl, M. Tsudzuki, J. Hiroi, M. Matsumoto, H. Ushio, S. Saito, P. W. Askenase, and C. Ra. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9: 461-466.
23. Inoue, J., S. Yotsumoto, T. Sakamoto, S. Tsuchiya, and Y. Aramaki. 2005. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice. J. Control. Release 108: 294-305.
24. Inoue, I., S. Yotsumoto, T. Sakamoto, S. Tsuchiya, and Y. Aramaki. 2005. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice. Pharm. Res. 22: 1627-1633.
25. Sakamoto, T., E. Miyazaki, Y. Aramaki, H. Arima, M. Takahashi, Y. Kato, M. Koga, and S. Tsuchiya. 2004. Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice. Gene Ther. 11: 317-324.
26. Imokawa, G., A. Abe, K. Jin, Y. Higaki, M. Kawashima, and A. Hidano. 1991. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96: 523-526.
27. Kline, J. N., T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A. M. Krieg. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160: 2555-2559.
28. Kline, J. N., K. Kitagaki, T. R. Businga, and V. V. Jain. 2002. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am. J. Physiol. 283: L170-L179.
29. Hussain, I., and J. N. Kline. 2003. CpG oligodeoxynucleotides: a novel therapeutic approach for atopic disorders. Curr. Drug Targets Inflamm. Allergy 2: 199-205.
30. Youn, C. J., M. Miller, K. J. Baek, J. W. Han, J. Nayar, S. Y. Lee, K. McElwain, S. McElwain, E. Raz, and D. H. Broide. 2004. Immunostimulatory DNA reverses established allergen-induced airway remodeling. J. Immunol. 173: 7556-7564.
31. Kitagaki, K., V. V. Jain, T. R. Businga, I. Hussain, and J. N. Kline. 2002. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses. Clin. Diagn. Lab. Immunol. 9: 1260-1269.
32. Kootiratrakarn, T., T. Fujimura, K. Sano, R. Okuyama, S. Aiba, H. Tagami, and T. Terui. 2005. Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model. Eur. J. Immunol. 35: 3277-3286.
33. Peng, Z., H. Wang, X. Mao, K. T. HayGlass, and F. E. Simons. 2001. CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to downregulate ongoing IgE responses in mice. Int. Immunol. 13: 3-11.
34. Yagi, R., H. Nagai, Y. Iigo, T. Akimoto, T. Arai, and M. Kubo. 2002. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J. Immunol. 168: 2020-2027.
35. + regulatory T cell subsets. J. Leukocyte Biol. 74: 471-478.
36. Sumiyoshi, K., A. Nakao, H. Ushio, K. Mitsuishi, K. Okumura, R. Tsuboi, C. Ra, and H. Ogawa. 2002. Transforming growth factor-β1 suppresses atopic dermatitis-like skin lesions in NC/Nga mice. Clin. Exp. Allergy 32: 309-314.
37. Huehn, J., and A. Hamann. Homing to suppress: address codes for Treg migration. 2005. Trends Immunol. 26: 632-636.
38. Takeshita, S., F. Takeshita, D. E. Haddad, K. J. Ishii, and D. M. Klinman. 2000. CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell Immunol. 206: 101-106.
39. Miller, L. S., O. E. Sorensen, P. T. Liu, H. R. Jalian, D. Eshtiaghpour, B. E. Behmanesh, W. Chung, T. D. Starner, J. Kim, P. A. Sieling, et al. 2005. TGF-α regulates TLR expression and function on epidermal keratinocytes. J. Immunol. 174: 6137-6143.